CHOP Cancer Researchers Win 2021 AACR Team Science Award miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Laura X. Vargas, PhD, MSW, MPA, Vice-Provost post-doctoral fellow at the Penn Injury Science Center at Penn Nursing and lead author of the study.. view more
Credit: Laura Vargas
PHILADELPHIA (April 8, 2021) - Many factors, including need, affect healthcare use. Strategies geared to enhancing the provision and access to healthcare must consider the various mechanisms that contribute to healthcare need and use. Until now, the mechanism of violence and its impact on both health and healthcare use has not been investigated.
A new study from the University of Pennsylvania School of Nursing (Penn Nursing) is one of the first to examine the association between violence exposure and healthcare service utilization in Mexico. Results are published in the
email article
Since the early days of the pandemic, researchers have been trying to use old drugs for new tricks, raising hopes and spurring controversy. Some of these, like hydroxychloroquine, turned out to be flops, while others are still debated. Recently, another old drug called fluvoxamine has come onto the scene.
MedPage Today explores how the old antidepressant has made its way to the COVID spotlight.
Fluvoxamine and the COVID Early Treatment Fund
Fluvoxamine is the poster child of the COVID-19 Early Treatment Fund (CETF). According to its founder, serial tech entrepreneur Steve Kirsch, CETF was started in April 2020 in order to fund drug repurposing research to find the fastest and most cost-effective early outpatient treatments for COVID-19. Kirsch told
89 Shares
The Oxford-AstraZeneca vaccine has been continually linked to blood clots, but there is a lot of misinformation out there. We thought we d break down everything you need to know.
There are multiple Covid-19 vaccines either already in circulation, or in the process of being approved. Each manufacturer and supplier goes through rigorous testing and is subject to approval for Emergency Use Authorisation by the World Health Organisation (WHO) and the relevant health authority of any given nation.
Advertisement
However, no matter how many checks and balances there are, people are always going to have anxieties and despite most people not knowing what s in their annual flu jab, they are hesitant or completely unwilling to receive a vaccine. But why?
Catholic high school hosts COVID vaccine clinic for teachers
A Philadelphia educator receives the second dose of the Pfizer COVID-19 vaccination at a March 31 clinic hosted by Archbishop Ryan High School. The initiative was the result of a collaboration among Children s Hospital of Philadelphia, the archdiocesan Office for Catholic Education, Faith in the Future, the School District of Philadelphia and independent schools. (Sarah Webb)
By Gina Christian • Posted April 6, 2021
Hundreds of local educators received their COVID vaccinations last week at an area Catholic high school, thanks to a collaboration among Children’s Hospital of Philadelphia (CHOP), the archdiocesan Office for Catholic Education (OCE), Faith in the Future, the School District of Philadelphia and independent schools.